OK
OKYO Pharma Limited
OKYO · NASDAQ
$1.36 -0.37% (-$0.01)
1M -9.33%
Market Cap $50.6M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$1.77
30.1% upside
Trenutna cena
$1.36
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica OKYO trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
49 /100
Fair P/B 4.11x
EV/FFO N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 68.97%
ROA 42.67%
Debt
69 /100
Low Int. coverage -17.87x
Debt/Equity 0.00x
Current ratio 2.43x
Stability
1 /100
Unstable Profitable years 0
Beta 0.05x
EPS volatility 11,489.68%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o OKYO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Robert J. Dempsey
Employees
5
Headquarters
London
Prihajajoči dogodki
02 DEC.
Earnings
Upcoming earnings report